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Abstract 
P2X receptors are a structurally and functionally distinctive family of ligand-gated ion 
channels that play important roles in mediating extracellular adenosine 5’-triphosphate 
(ATP) signalling in diverse physiological and pathophysiological processes. For several 
decades, the ‘manual’ patch-clamp technique was regarded as the gold standard assay for 
investigating ion channel properties. More recently, breakthroughs in the development of 
automated patch-clamp technologies are enabling the study of ion channels, with much 
greater throughput capacities. These automated platforms, of which there are many, 
generate consistent, reliable, high fidelity data. This chapter demonstrate the versatility of 
one of these technologies for ligand-gated ion channels, with particular emphasis on 
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protocols that addresses some of the issues of receptor desensitization that are commonly 
associated with P2X receptor-mediated currents. 
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1. Introduction 
P2X receptors (P2XRs) belong to the ligand-gated ion channel superfamily with distinctive 
structural and functional properties [1]. In the mammalian system, there are seven different 
receptor subunits (P2X1R-P2X7R), each of which contains intracellular N- and C-termini 
and two transmembrane segments linked by a large extracellular domain. P2XR subunits 
assemble into homo- or hetero-trimeric complexes to form functional channels. Th  second 
transmembrane domain from each of the three subunits, in the complex, forms the ion-
permeating pathway [2-3]. Extracellular ATP binding specifically activates P2XRs leading 
to variable permeation of small inorganic cations such as Ca2+, N + and K+, with the 
exception of the human P2X5R, which also conducts Cl- ions [4]. There are three phases 
associated with gating of P2XRs: the ATP-evoked activation or rising phase that induces 
a rapid current, the desensitization or decay phase that occurs in the presence of ATP and 
develops slowly, and a relatively quick deactivation phase elicited by removal of the 
agonist. The kinetics of these three phases vary considerably among the different P2XR 
subtypes [5]. In addition, recurrent application of ATP, results in the attenuation of current 
responses [6]. P2XRs exhibit widespread expression patterns in neuronal and non-neuronal 
tissue, where they play important roles in mediating a diverse range of physiological 
functions [2, 7]. While there is evidence for localization in intracellular organelles such as 
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lysosome, P2XRs are predominantly expressed within the plasma membranes or on the 
cell surface [8, 9]. A large body of evidence supports the involvement of P2XRs in a 
number of human pathologies and diseases [2, 7, 10], identifying them as attractive 
therapeutic targets for precision medicine [11]. 
 
The manual patch-clamp technique was developed as the benchmark to measure ionic 
currents flowing through open channel pores [12-13], thereby enabling the investigation 
of the biophysical properties of ion channels, testing of therapeutic compounds and 
examination of mechanisms of action. The manual patch-clamp recording technique has 
certain limitations, in that extensive technical training is required, and data acquisition is 
generally low, necessitating a large time investment. Automated technologies have been 
extensively used for pharmaceutical drug discovery for some time now and as research 
groups combine resources, automated patch-clamp systems are becoming a more 
commonplace feature in academic laboratories. Numerous first and second generation 
platforms have been manufactured over the last two decades, including: QPatch HTX, 
QPatch II, Qube 384 (Sophion A/S, Copenhagen); PatchXpress® 7000A, IonWorks® 
Quattro, IonWorks Barracuda™ (Molecular Devices, LLC); NPC-16 Patchliner®, 
SyncroPatch® 96 SyncroPatch® 384PE (Nanion Technologies GmbH, Munich); 
CytoPatch™ (Cytocentrics AG, Rostock); Dyna flow® HT (Cellectricon AB, Mölndal); 
and IonFlux HT (Fluxion Bioscience Inc. USA). Data output from these platforms, is 
generally highly comparable to the high fidelity data acquired using the manual patch-
clamping technique [14]. Here we describe protocols using the first generation platform 
Patchliner, as an example, to measure agonist-induced P2XR-mediated whole-cell currents 
from stably transfected or transiently transfected cells. For most automated patch-clamp 
systems on the market it is challenging to use transiently transfected cells, because of the 
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blind approach of capturing cells. Interestingly, robust currents from HEK293 cells 
transiently expressing P2X4Rs were recorded using the Patchliner [15]. Patchliner has 
built-in robotic, microfluidic, liquid handling capabilities [16], allowing the complete 
application and washout of agonist in a millisecond time frame [17], making it an ideal 
platform for measuring rapidly activating, desensitizing, ligand-gated currents. It should, 
however, be noted that many of the features and notes given in this chapter can be applied 
to other automated systems, similarly. 
 
2. Materials 
2.1 Reagents and Cells 
1. Human embryonic kidney (HEK) 293 host cells, HEK293 cells stably expressing the 
human P2X7 receptor (hP2X7R) and human astrocytoma cells (1321N1) stably 
expressing P2X2R and P2X3R subunits (P2X2/3R). 
2. HEK293 cell culture media: Dulbecco’s Modified Eagles Medium (DMEM), 2 mM 
L-glutamate and 10% fetal bovine serum (FBS). 
3. DMEM/F-12 complete media: DMEM/F-12 liquid, 10% FBS, 2 mM L-glutamate, 
10% FBS. 
4. 1321N1 cell culture media: DMEM, 10% FBS, 50 U/mL penicillin and 50 µg/mL 
streptomycin. 
5. D-PBS: Dulbecco’s phosphate buffer saline Ca2+ and Mg2+ free.  
6. Accutase® cell detachment solution (Invitrogen) or similar. 
7. Opti-MEM I reduced serum media (Invitrogen) or similar. 
8.  Transfection reagent, Lipofectamine 2000 transfection (Invitrogen) or similar. 
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9.  DNA plasmids: empty plasmid vector for mammalian expression of GFP, full-length 
P2X4-WT-AcGFP (WT), mutant P2X4-G135S (G135S) constructs. DNA contructs 
were generated in-house. 
10. 100 mM Adenosine triphosphate (ATP) and its analogues (e.g. BzATP) in water as 
stock solutions. Adjust ATP stock solution to pH7.3 with NaOH. Aliquot ATP and 
BzATP stock solutions in small volumes, and store at -20 oC. Prepare working 




1. Vented flasks for cell culture (T25). Conical centrifuge tubes (15 mL). 
Microcentrifuge tubes 1.5 mL. 
2. Pipettes and tips 10-, 20-, 200-, and 1000 たL and Easypet pipetting aid and Maxitips 
5 mL. 
3. High speed bench top centrifuge. 
4. CountessTM automated cell counter (ThermFisher Scientifc) or a haemocytometer and 
trypan blue. 
5. NPC®-16 Patchliner Probe Selector/Quattro/Octo (see Note 1), PatchControlHT 
software, single-hole (Fig. 1a), 4-hole ensemble (Fig. 1b) or 8-hole ensemble NPC®-
16 chips (see Note 2). NPC®-16 electrode set (see Note 3) (Nanion Technologies 
GmbH). 
6. Patch-clamp amplifiers (PATCHMASTER, HEKA Instruments) (see not 4). 
7. Computer with 24-inch thin film transistor monitor (see Note 5). 
8. Multi-channel stimulation/acquisition software with programmable experiment 
control and automation (HEKA Instruments) and analysis packages (such as Microsoft 
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Excel, MatLab R2018a), Igor Pro 6.37 (WaveMetrics Inc.), Adobe Illustrator CS5.1 
(Adobe Systems) and GraphPad Prism 7 (Molecular Devices). 
9. 50 mL syringe with 0.22-たm-pore diameter filter.  
10. Bench top pH metre. 
11. Advanced Instruments Osmo1, single sample micro-osmometer. 
 
2.3. Planar Patch-Clamp Solutions 
Prepare solutions with deionized water, filter (see Note 6) and measure the osmolarity (see 
Note 7) and the pH (see Note 8). Solutions can be stored at 4 °C for up to 5 days. Solutions 
should be warmed to room temperature (20–22 °C) before use. The built-in robotic pipette 
manages all liquid handling requirements. Solutions are aspirated from the preprogrammed 
positions on the workstation and dispensed into the appropriate chip chamber. The pipette 
is capable of aspirating and dispensing a single solution (Fig. 1a, b), double stacked (Fig. 
1c) or triple stacked solutions [17], the later allowing the application of a channel 
modulator prior to agonist. 
1. Standard extracellular solution for recording with HEK293 cells stably expressing 
hP2X7Rs: 147 mM NaCl, 2 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 13 mM D-glucose, 
10 mM HEPES (pH 7.3 with NaOH; ~298 mOsm). 
2. Standard extracellular solution for recording with HEK293 cells transiently expressing 
P2X4Rs: 145 mM NaCl, 2 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 13 mM D-glucose, 
10 mM HEPES (pH 7.4 with NaOH; ~298 mOsm). 
3. Standard extracellular solution for recording with 1321N1 cells stably expressing 
P2X2/3Rs: 140 mM NaCl, 4 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 5 mM D-glucose, 
10 mM HEPES (pH 7.4 with NaOH; ~298 mOsm). 
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4. Standard extracellular solution for enhancing seals: 80 mM NaCl, 3 mM KCl, 10 mM 
MgCl2, 35 mM CaCl2, 10 mM HEPES (pH 7.4 with HCl) (see Note 9). 
5. Standard intracellular solution for whole-cell recordings with HEK293 cells stably 
expressing hP2X7Rs: 85 mM NaCl, 60 mM NaF, 10 mM EGTA, 10 mM HEPES 
(pH 7.2 with NaOH; ~285 mOsm). 
6. Standard intracellular solution for whole-cell recordings with HEK293 cells 
transiently expressing P2X4Rs: 85 mM NaCl, 60 mM NaF, 10 mM EGTA, 10 mM 
HEPES (pH 7.2 with NaOH; ~285 mOsm) (see Note 10). 
7. Standard intracellular solution for whole-cell recordings with 1321N1 cells stably 
expressing P2X2/3Rs: 110 mM KF, 10 mM KCl, 10 mM EGTA, 10 mM HEPES 
(pH 7.2 with KOH; ~285 mOsm). 
 
3. Methods 
3.1 Cell Culture and Transient Transfection 
The following procedures should be conducted in a sterile tissue culture fume hood. 
1. Culture HEK293 host cells in standard T25 tissue culture flasks in HEK293 cell 
culture media in humid 37 oC, 5% CO2 tissue culture incubator, until 60% confluent. 
2. Culture HEK293 cells, stably expressing hP2X7R, in standard T25 tissue culture flasks 
in DMEM/F-12 complete media and incubate in a humid 37 oC, 5% CO2 tissue culture 
incubator, until sub-confluent (70-80%). 
3. Culture 1321N1 cells, stably expressing P2X2/3R, in standard T25 tissue culture flasks 
in 1321N1 cell culture media at 37 oC in a humidified atmosphere composed of 95% 
air and 5% CO2, until sub-confluent (70-80%). 
4. Cells should be passaged every 2-3 days using Accutase® cell detachment solution 
and confluency should be sub-confluent (60-80%) (see Not 11). 
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5. For each transfection, dilute 3 たg of selected cDNA:pAcGFP-N1 empty vector 
(Mock); P2X4-WT-AcGFP wild-type (WT) or P2X4-G135S (G135S) with Opti-MEM 
I reduced serum media (total volume 200 たL) in a 1.5 mL tube and in a second tube, 
add Lipofectamine 2000 Reagent (30 たL) with Opti-MEM I reduced serum media (170 
たL), mix contents of each tube thoroughly by gentle pipetting.  
6. Incubate both tubes at room temperature for 5 min.  
7. Combine contents of the two tubes, mix thoroughly by gentle pipetting and incubate 
at room temperature for 20 min.  
8. Add this transfection media to HEK293 host cells cultured to 60% confluency in a 
standard T25 flask and return to the incubator.  
9. After 24 hours replace the transfection media with normal culture media and return to 
the incubator for a further 24 hours (see Note 12). 
 
3.2 Harvesting Cells for Planar Patch-Clamp 
A critical feature determining the success rate of planar patch-clamp recordings is that the 
healthy cells are maintained at the optimum sub-confluency. The process of capturing cells 
is completely random, so unlike conventional patch-clamp recording, it is not possible to 
visually select the healthiest looking cell. In addition, the quality of the seal formed 
between the cell membrane and the planar chip, which ultimately influences the quality of 
the recording, is reliant on the health of the cell. 
1. Discard the media from the culture flask and, using 5 mL D-PBS, gently wash the cells 
twice. 
2. Discard the D-PBS and dissociate with 0.5 mL pre-warmed Accutase cell detachment 
solution and gently tilt the flask from side to side to cover all the cells. Incubate for 
3 min in a humid 37 oC, 5% CO2 tissue culture incubator (see Note 13). 
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3. To neutralize the Accutase, add 5 mL culture media and pipette up and down gently 
in order to lift and separate the cells. 
4. Transfer the cell suspension to a 15 mL conical centrifuge tube and centrifuge at 
180 捲 訣 for 2 min at room temperature and then discard the supernatant by decanting 
(see Note 14). 
5. Resuspend the cell pellet by gently pipetting in a mixture of extracellular recording 
solution and culture media (50:50 ratio, see Note 15) at a density of 1 x 106 to 5 x 107 
mL (see Note 16). Cells can be counted using a Countess automated cell counter, 
although a standard hemocytometer is quite adequate. 
6.  Transfer the cells, in suspension, to the cell hotel (see Note 17). 
 
3.3 Automated Planar Patch-clamp using Patchliner 
The Patchliner software (PatchControlHT) is coupled to the HEKA amplifier software 
(Patchmaster), via the optical PCI card in the computer, and when PatchControlHT is 
opened, Patchmaster opens automatically. This allows the experimental protocols 
(PatchControlHT Trees), programmed in PatchControlHT, to communicate with the 
amplifiers. Pre-programmed Trees can be loaded and modified for optimisation with 
different cell types/characteristics. Selection of appropriate chip cartridges, with the 
resistance suitable for cells of a particular size, is important (see Note 18). The motorized 
stage on the workstation of the Patchliner (‘chip-wagon’) has the capacity to hold three 
chip cartridges and each cartridge allows data acquisition from sixteen cells (eight at any 
given time), hence allowing for 48 recordings without operator intervention. Chip 
cartridges are embedded with microfluidic chambers and when a PatchControlHT Tree is 
activated, the pipetting robot dispenses appropriate recording solutions into the 
microfluidic chambers of the chip and the cartridge is moved into the measuring head, 
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which contains the pneumatic and electric contacts and moves up and down to address the 
chip cartridges. The recording head houses eight headstages, allowing acquisition of data 
from eight cells simultaneously. Once the intracellular and extracellular solutions have 
been dispensed, a slight positive pressure is applied to each chip chamber, independently, 
and the offsets are corrected. Cells from the cell hotel are dispensed into the extracellular 
chamber and a small suction (-50 mBar) is applied, to attract cells onto each of the eight 
individual chip apertures, leading to a small increase in the seal resistance. Seal enhancing 
solution is then added and further suction pulses applied, together with application of 
negative voltage to aid in the formation of a gigaohm seals. The seal enhancing solution is 
then replaced with recording solution before additional short suction pulses are applied to 
achieve the whole-cell access.  In some circumstances, it may be necessary to support this 
process using the zap function to encourage the patch of membrane to rupture (see Note 
19). The pressure applied during this process is controlled by PatchControlHT parameter 
settings (e.g. chip resistance, series resistance and slow capacitance), that the user can 
adjust according to the cell type/characteristics. It is also possible to adjust quality control 
parameters (e.g. seal resistance, series resistance), so cells that do not meet the 
specifications are disabled at this stage. Once the whole-cell configuration has been 
established, the experimental part of the protocol will commence. 
1. Load a pre-programmed PatchControlHT ligand Tree (File → load → Tree) and select 
the edit mode ( Edit) to make modifications according to cell/channel/receptor 
type/characteristics, and experimental paradigm (see Not  20). 
2. Select chips with the desired resistance and format for cells/receptors and place three 
chips onto the chip-wagon. 
3. Prepare compound solutions directly before each experiment (see Note 21). 
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4. Place recording solutions and compounds in position, according to those defined in 
the joblist (see Note 22). 
5. Place the cells into the cell hotel, where they will be aspirated every 30 s throughout 
the experiment to prevent clumping and sedimentation (see Note 23). 
6. Select and activate the initialization folder to initialize the robot and wash the pipette. 
This also generates a new data file within Patchmaster and sets all amplifier and robot 
parameters to default starting values. This folder only needs to be activated once at the 
beginning of each day of experiments. 
7. The robot will start when the Tree is activated. At the end of each run, it will loop back 
to the start and continue this process until all chips on the chip-wagon have been used. 
Illustrative automated planar patch-clamp recordings from HEK293 cells stably expressing 
the WT hP2X7R (Fig. 2). Cells were captured on single-hole chips and voltage-clamped at 
a holding potential of -60 mV while a continuous recording performed data acquisition. 
BzATP, applied at a rate of 86 ʅL/s (speed 15), activated inward currents in a 
concentration-dependent manner. No desensitization was observed in the continued 
presence of BzATP. These recordings did not utilise a stacked solution application, ligand 
was applied independently of the external solution. 
 
3.4 Stacked Solution Application 
P2XRs exhibit receptor desensitization [5], which is a common characteristic feature of 
ligand-gated ion channels. The kinetics and level of desensitization of ligand-gated ion 
channels are determined by ligand concentration and exposure time, or both. For rapidly 
desensitizing ion channels, it is important that compound application is rapid and short-
lived, so that the entire ion channel population is exposed to maximum concentration 
before entering the desensitized state. Therefore rapid solution exchange combined with 
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brief drug exposure times can minimise or correct for the deleterious effect caused by 
receptor desensitisation. This is achieved by using a stacked solution application, whereby 
two or three zones of solution are aspirated into the pipette before they are dispensed into 
the chamber, where they have brief and rapid contact with the cell/s (Fig. 1, see Note 24). 
1. Load a pre-programmed ligand Tree for double stacked solution application. Volumes 
and speeds of applications can be adjusted (see Not  25). In addition, if required, 
temperature can also be controlled (see Note 26). 
2. Select medium resistance chips (2-4 MΩ). For HEK293 stably expressing P2X4Rs, 
single-hole chips were utilized and for 1321N1 cells stably expressing P2X2/3Rs 4- or 
8-hole ensemble chips were selected. Load three chips onto the chip-wagon. 
3. Within the Tree, adjust the holding potential and the required speed of drug/wash 
delivery. The joblist will contain a continuous recording protocol, for fast ligand 
activated currents. The duration of the continuous recording can be modified in the 
Patchmaster pulse generator file. 
4. Follow steps 3-6 in section 3.3. 
In the example shown in figure 3a, HEK293 cells transiently expressing AcGFP vector, 
WT P2X4-AcGFP, or P2X4-G135S-AcGFP were voltage-clamped at a holding potential of 
-50 mV, utilizing single-hole chips. 100 たM ATP applied for 700 ms, rapidly activated 
robust inward current for WT and mutant hP2X4R, which desensitized slowly in the 
presence of ATP. No currents were elicited for cells transfected with mock vector control 
alone, which is reflected in the mean peak current amplitudes (Fig. 3b). 
 
Figure 4 shows the reproducibility of responses to repetitive activation of robust inward 
currents, from 1321N1 cells stably expressing the P2X2/3R, in response to 30 ʅM ATP 
applied using a stacked application protocol. The time course demonstrates, very elegantly, 
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that there is little effect on the peak current amplitude in response to brief repetitive 
application of agonist. 
 
Representative current responses of an individual cell expressing P2X2/3Rs to increasing 
concentrations of ATP are shown in Figure 5a. The currents exhibit a slow desensitization 
phase in the continued, but brief, presence of 30 ʅM ATP. The concentration response 
curve revealed an EC50 for ATP activation of 7.8 ± 1.0 たM (Fig. 5b). P2X2/3Rs could be 
repetitively activated by 30 ʅM ATP and blocked by suramin (Fig 5c) in a dose-dependent 
manner. A full concentration response curve to suramin was performed, generating an IC50 
of 28.0 ± 5.3 たM (Fig. 5d). To achieve short exposure times, solutions were stacked in the 
robotic pipette. First, wash solution (155 たL) was aspirated, followed by aspiration of the 
agonist-containing solution (40 たL) and then application to the cell at a speed of 57 たL/s. 





1. NPC®-16 Patchliner Quattro or Octo are being used here, as an example of a validated 
automated patch-clamp system, but it should be noted that other systems have 
comparable capabilities. 
2. NPC®-16 chips (single use, disposable) are manufactured with different 
specifications. In general, chips are manufactured with three different megaohm (M) 
resistance ranges: low (1–2 MΩ), medium (2–4 MΩ) and high (5–6 MΩ). It is also 
possible to have bespoke chips manufactured according to the specific requirements 
of the user and/or cell type. Single-hole chips are ideal for use with voltage-gated 
channels. For ligand-gated channels, ensemble chips are generally preferred, 
especially if  currents are small in amplitude. Ensemble chips are manufactured with 
either four or eight holes per chip, which is ideal for enhancing current size, because 
the currents are summated. 
3. Electrodes need to be chloridated in bleach filled chambers for 30-60 min and then 
rinsed with deionized water and air dried before use. 
4. Patchliner Quattro and Octo, use either EPC-10 USB Quadro multi-headstage patch-
clamp amplifiers or the EPS 16 Probe Selector headstage multiplexer, combined with 
an EPC 10 Plus amplifier (HEKA Instruments). 
5. Any brand of computer can be purchased, but minimum specifications include 
Windows 10 (Microsoft) with a 64-bit operating system and an optical PCI card for 
communication with the HEKA amplifiers. 
6. Sterile filter all recording solutions using a 50 mL syringe with a 0.22-たm-pore 




7. Measure the osmolarity of all recording solutions using a freezing-point osmometer. 
The internal solutions should measure ~285 mOsm/L and the external solutions should 
measure ~298 mOsm/L. The osmolarity of external solutions should always be higher 
than the osmolarity of the internal solution. 
8. When pH adjusted stock solutions (1 M), of each salt, are used to make the final 
recording solutions, then the osmolarity should not require further adjustment. 
9. A high Ca2+-containing external solution helps in the formation of a strong seal 
between the cell membrane and the planar chip. This seal enhancing solution is 
replaced once a gigaohm seal is achieved and before establishing whole-cell access. 
Calcium in the extracellular solution can be replaced by barium as charge carrier, to 
avoid calcium-dependant inactivation of voltage-gated calcium channels and increase 
calcium channel currents, since most voltage-gated calcium channels also conduct 
barium ions [18-19]. 
10. Fluoride ions in the intracellular solution improve gigaohm seal formation and 
stabilise the cell membrane, which in turn results in longer, more stable recordings 
[20]. The mechanism of this effect is poorly understood. 
11. To avoid cells growing in clusters or adhering too tightly to the support substrate, it is 
vital that they are passaged every 2-3 days. If cells are allowed to grow to a confluency 
greater than 80%, aggregates commonly form, which in turn lead to lower capture 
rates, poor seal formation and difficulties breaking into the whole-cell configuration. 
Furthermore, dissociation buffers encourage cell separation and isolation. 
12. A Lipofectamine 2000 Reagent protocol, available at (ht ps://www.ecu.edu/cs-
dhs/biochemistry/upload/Transfection-Protocol.pdf), was used to transiently transfect 
the cells. It should be noted that other transfection kits are also suitable for transient 
expression of ion channel proteins. 
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13. Accutase® cell detachment solution gently dissociates mammalian cells from support 
substrates and from each other. It should be stored at 4oC nd used at room temperature 
in sterile conditions. 
14. To prevent shearing of the cell membranes during centrifugation, it is recommended 
to set the centrifuge acceleration speed to 6 and deceleration speed to 3. The value 0 
is equivalent to the lowest acceleration and the value 9 is equivalent to the highest 
acceleration. The value 9 is equivalent to the shortest possible brake time and the value 
0 to longest possible brake time. 
15. When cells are resuspended in a mixture of recording solution and culture media 
(50:50), their bench life is greatly improved, and they remain viable for up to 4 h at 
room temperature. 
16. A standard density of 1 x 106-5 x 107 cells/mL, for most cell types, works well for use 
on the Patchliner. When working with primary cells, it is often challenging to harvest 
such large numbers of cells. It is possible to maintain a good cell capture rate with as 
few as 1000 cells/mL [21]. 
17. Cells are housed in the ‘cell hotel’, where they are kept from clumping and 
sedimenting by gentle automated pipetting, which improves cell viability. The user 
can set the pipetting volume and speed. 
18. The capacitance of the cell, determines the size of the aperture (chip resistance) 
required. As an example, medium resistance chip are ideal for use with HEK293 cells 
and CHO cells [16, 22] and high resistance chips are ideal for use with mouse 
osteoblasts [23]. For example, if cells are very small, they will pass through a low 
resistance chip hole when suction is applied, and conversely, large cells will not form 
good seals on high resistance chips. 
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19. If it is difficult to establish the whole-cell configuration, following seal formation, then 
try harvesting the cells one day after plating. In addition, adjust the size of the high 
voltage pulses to 600–800 mV (‘zap’), which can be applied to help rupture the patch 
of membrane, thus establishing the whole-cell configuration. 
20. PatchControlHT comes with a range of pre-programmed protocols (‘Trees’), which 
have numerous experimental paradigms (e.g. Ligand, IV, Pharm), for specific cell 
characteristics (e.g. cell capacitance, membrane fragility) and channel types (e.g. 
P2XR, Na+ or K+ channels). Features of a Tree can be adjusted, enabling the user to 
modify amplifier and suction parameters and also allows access to commands that can 
be inserted into a Tree via a generic drag-and-drop function. In addition, once a Tree 
has been optimized for a particular cell type, it will not normally require modification 
for future use with the same cell type. Application notes are available t 
http://www.nanion.de. 
21. Prepare fresh compound solutions, directly prior to use, to avoid precipitation. 
Compound solutions, where possible should be stored in glassware, because some 
compounds will adhere to other substrates. An underestimation of concentration may 
result from adhesion or precipitation of a compound solution. 
22. The joblist, within the Tree, defines the position of the compounds, the volume and 
speed of application and selection of the appropriate pulse generator file in 
Patchmaster. 
23. Regular aspiration of cells retain viability for at least 4 h after they have been prepared 
in suspension, although some deterioration in success rates has been observed after 3 
h. 
24. For a double stack with two zones of solution, the wash buffer is aspirated first, 
directly followed by the ligand resulting in the ligand zone being applied to the cells 
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first, followed immediately by the wash buffer (Fig. 1c). To examine the effects of a 
channel modulator, a triple stack with three solution zones should be selected [17]. 
The wash buffer is aspirated first, followed directly by solution containing both ligand 
and modulator, followed immediately by modulator. 
25. The volumes of the different solution zones can be adjusted, as well as the speed of 
application, enabling exposure times of as little as 100 ms. Typical volumes for a 
double stack are 200 ʅL wash buffer zone, 10-60 ʅL ligand zone, but these can be 
optimised for different ligands, accordingly. The maximum volume that the pipette 
can aspirate at one time is 350 ʅL. The zone containing the ligand should be applied 
more rapidly (e.g. 171 ʅL/s; speed 12) than the other zones (e.g. 19 ʅL/s; speed 24). 
In addition it is possible to set the volumes to be dispensed at different rates and these 
do not need to correspond the volume of the two phases (e.g. ‘Vol fast’ 120 ʅL (Speed 
12) and ‘Vol slow’ 140 ʅL (Speed 24). 
26. The recording chamber, chip-wagon and pipette can be heated simultaneously or 
independently. These modules can be heated to 80 oC, however, it is not recommended 
to increase the temperature above 55 oC. The temperature of the cells and the solutions 
can also be cooled via an add-on cooling plate. Cooling the cells and compounds 
improves viability and stability. 
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6. Figure Legends 
Fig. 1 Schematic of the cross-section of chip chamber micro-domains, illustrating single 
and double stacked solution application. (a) Example of a chip chamber with a cell sealed 
on the single chip aperture. The robotic pipetting arm dispenses, solutions, cell suspensions 
and compounds into the chip. With every addition to the external micro-channel, the 
solution is completely replaced, overflowing into the waste reservoir. The waste reservoir 
is emptied throughout the experiment. (b) Cross-section of a 4-hole ensemble chip, 
illustrating the arrangement of four cells simultaneously sealed onto f ur individual 
apertures in a single chip chamber. (c) Illustration of double stacked solution application. 
The robotic pipette aspirates external solution (Wash) followed by ligand of interest (Drug) 
before precisely timed application into the external micro-channel. Output from the 
recording electrode showing the brevity of drug contact with the cell during a continuous 
recording (Modified from [17]) 
 
Fig. 2 BzATP concentration-response curve obtained from WT hP2X7Rs stably expressed 
in HEK293 cells. Data are fit to the Hill equation with the following EC50 value: 69.7 ± 
7.5 ʅM and Hill coefficient: 2.3 ± 0.5 (n = 8 for each data point). Inset shows representative 
whole-cell currents evoked by BzATP (3–100 ʅM). Cells were voltage-clamped at a 
holding potential of -60 mV. (Reproduced from [16]) 
 
Fig. 3 P2X4R functional assay using HEK293 cells transiently transfected with AcGFP, 
WT P2X4-AcGFP, or P2X4-G135S-AcGFP. (a) Representative whole-cell current traces 
from WT P2X4 (dark grey) and G135S mutant P2X4 (light grey) in response to ATP (100 
µM) as indicated by the bar above the current traces. No currents were elicited for cells 
transfected with AcGFP empty vector alone (Mock; black). (b  Mean peak current 
23 
 
amplitude for Mock (black; n = 6), WT P2X4 (dark grey; n = 6 cells) and G135S P2X4 
(light grey; n = 10 cells) in response to ATP (100 µM). A volume of 60 ʅL ATP was 
applied at a rate 86 ʅL/s; (speed 15), followed immediately by wash (120 ʅL) at a rate of 
19 ʅL/s (speed 24), using a double stacked protocol. Peak currents were compared and 
statistical significance marked as *p<0.01. (Reproduced from [15] with permission from 
Wiley) 
Fig. 4 Repetitive activation of P2X2/3R. (a) Current traces induced, in a single 1321N1 cell, 
by repetitive application of ATP (30 ʅM) using a double stacked solution application 
protocol. Black bars above the current traces illustrate ATP (30 ʅM) contact time. (b) 
Timecourse of the experiment showing 7 reproducible inward currents with consistent 
current amplitudes of approximately 8 nA 
 
Fig. 5 Effects of ATP and suramin on P2X/3Rs stably expressed in 1321N1 cells. (a) 
Representative current traces showing activation of P2X2/3Rs by increasing concentrations 
of ATP (0.1–300 ʅM). (b) Mean dose-response curve for ATP activation. Data are fit to 
the Hill equation with the following EC50 value: 7.8 ± 1.0 たM and Hill coefficient: 1.2 ± 
0.065 (n = 10 for each data point). (c) Representative traces showing the concentration-
dependent block of ATP-induced P2X2/3Rs currents by suramin (1 ʅM–1 mM). Suramin 
at increasing concentrations was pre-incubated and then co-applied with 30 たM ATP. (d) 
Concentration-response curve for suramin block. Data are fit to the Hill equation with the 







7. Figures  
 
 
Figure 1  
 
 
25 
 
 
Figure 2 
 
Figure 3 
 
26 
 
 
Figure 4 
 
Figure 5 
